Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function

Gene therapy for inherited retinal diseases has been shown to ameliorate functional and structural defects in both animal models and in human clinical trials. X-linked retinoschisis (XLRS) is an early-age onset macular dystrophy resulting from loss of an extracellular matrix protein (RS1). In prepar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Gene Ther
Autors principals: Bush, Ronald A., Zeng, Yong, Colosi, Peter, Kjellstrom, Sten, Hiriyanna, Suja, Vijayasarathy, Camasamudram, Santos, Maria, Li, Jinbo, Wu, Zhijian, Sieving, Paul A.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2016
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840830/
https://ncbi.nlm.nih.gov/pubmed/27036983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2015.142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars